Phase I Study of Intralesional Bacillus Calmette-Guerin (BCG) Followed by Ipilimumab in Advanced Metastatic Melanoma
Clinical trial NCT01838200 · TERMINATED
Trial details
- NCT number
- NCT01838200
- Sponsor
- Ludwig Institute for Cancer Research
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2015-08-17
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.